Innoviva, Inc. (INVA) Cash Flow Statement

The gap between net income and operating cash flow is the central signal in this dataset, with operating cash flow to net income ratios ranging from -0.62 to 0.69 in the most recent quarters. This pattern suggests that large non-cash or non-operating items, such as impairments, fair value changes, or amortization tied to the royalty and acquisition accounting, are driving reported earnings more than underlying cash generation. Investors should monitor the reconciliation between these two figures before treating either as a reliable proxy for earning power.

The compression in free cash flow margin from the mid-50s to the high-30s is consistent with the shift toward lower-margin product revenue and rising commercial overhead noted in prior analysis. Capital expenditure remains negligible relative to revenue, so the margin decline reflects operating cost structure rather than reinvestment demands. This suggests the underlying royalty engine is still generating cash, but its contribution is being diluted by the newer operating segments.

The company paid no dividends across the period, directing its free cash flow toward repurchases and acquisitions instead. This dual deployment suggests management is willing to fund growth from cash generation rather than external debt, which is consistent with the adequate balance sheet rating. Whether this allocation creates value depends on whether acquired assets such as the infectious disease products reach commercial scale, a question the cash flow data alone cannot resolve.

Summing the reported quarters, operating cash flow totals roughly $470M against net income near $200M, a divergence driven largely by the negative net income quarters in 2024Q2, 2025Q1, 2026Q2, and 2026Q3. This pattern may reflect non-cash charges that are excluded from cash flow but included in earnings, or the reverse, and the reasons are not identified in the available data. Such a gap warrants further investigation before drawing firm conclusions about earnings durability.